Lung Cancers Withdrawn Phase 1 / 2 Trials for Sorafenib (DB00398)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Withdrawn1 / 2 IdentifierTitlePurposeDrugs
NCT00547443Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment